Skip to content

News

FINANCIAL HIGHLIGHTS 1 April – 30 June 2019 TOTAL OPERATING COSTS SEK 28.1M (11.5M) NET RESULT -25.8M (-9.7M) CASH AND CASH EQUIVALENTS (30 JUNE...
“This is a crucial milestone. Full enrolment means we are on track to deliver top-line results in late March 2020 as promised. It also shows how...
“The FDA IND approval in menstrual migraine is an important validation of the strong safety profile of our compound and also has very positive implications...
The paper, Isoallopregnanolone reduces tic-like behaviors in the D1CT-7 mouse model of Tourette syndrome is co-authored by, amongst others, Marco Bortolato...
“The symptoms are severe enough to cause significant distress or impairment… and do not represent the exacerbation of a mental disorder&rdquo...
The share issue has been triggered by the reaching of a planned milestone in the PMDD study, and it represents 1.5% of the current share capital in Asarina...
The PMS & PMDD evening will take place at the University of Gothenburg, Sprängkullsgatan 19, 1700-1930. It has been organised by Isabel Lindström...
Financial Highlights The company maintained a strict management of its costs. The total cash position at the end of the Quarter was SEK 128.9 million...
Dividend In accordance with the board's proposal, the AGM resolved that no dividend is to be paid for the financial year 2018. Discharge from liability...
Dividend In accordance with the board's proposal, the AGM resolved that no dividend is to be paid for the financial year 2018. Discharge from liability...